Evidence map›Paper›PMID 37259825›Full record

ArticleThe European journal of general practice2023

Fear of COVID-19 among patients with prior SARS-CoV-2 infection: A cross-sectional study in Estonian family practices.

Amanda Soomägi, Tatjana Meister, Sigrid Vorobjov, Kadri Suija, Ruth Kalda, Anneli Uusküla

Open access · goldAbstract read
In one paragraph

Article in The European journal of general practice, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Amanda SoomägiInstitute of Family Medicine and Public Health, University of Tartu, Tartu, Estonia.ORCID 0000-0003-3923-6750
Tatjana MeisterInstitute of Family Medicine and Public Health, University of Tartu, Tartu, Estonia.ORCID 0000-0002-4213-6657
Sigrid VorobjovThe National Institute of Health Development, Tallinn, Estonia.ORCID 0009-0006-0248-6026
Kadri SuijaInstitute of Family Medicine and Public Health, University of Tartu, Tartu, Estonia.ORCID 0000-0003-3364-7372
Ruth KaldaInstitute of Family Medicine and Public Health, University of Tartu, Tartu, Estonia.ORCID 0000-0002-8434-0592
Anneli UuskülaInstitute of Family Medicine and Public Health, University of Tartu, Tartu, Estonia.ORCID 0000-0002-4036-3856
University of Tartu · EENational Institute for Health Development · EE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFear of coronavirus disease (COVID-19) has been associated with significant health effects.

objectivesTo assess COVID-19 fear and investigate factors associated with higher fear among COVID-19 survivors over 6 months after infection.

methodsCross-sectional study using multistage sampling (family practices within the highest 5th percentile of numbers of SARS-CoV-2 infected patients and random sample of patients within these practices) performed from March 15 to 17 July 2021. Adult patients with a laboratory-confirmed history of COVID-19 were recruited for a self-administered 79-item questionnaire including demographics, self-rated health, physical activity, COVID-19 characteristics, severity and the fear of COVID-19 Scale (FCV-19S). Comorbidity data were extracted from Estonian Health Insurance Fund. Logistic regression models were used to evaluate factors associated with COVID-19 fear.

resultsOf 341 participants included, 60% were women, 24.2% were hospitalised due to COVID-19 and 22.2% had long COVID, 143 (42%) participants reported high levels of fear (cut-off FCV-19S >17.8). Higher fear was associated with being female (aOR 2.12, 95% CI 1.14-3.95), age ≥61 years (aOR 3.23, 95% CI 1.28-8.16), two-member-households (aOR 3.70, 95% CI 1.40-9.77) physical inactivity 6 months prior to COVID-19 (aOR 3.53, 95% CI 1.26-9.95), and symptom severity during acute COVID-19. Long COVID was not associated with higher COVID-19 fear (aOR 1.82 95% CI 0.91-3.63).

conclusionAlmost half of participants reported COVID-19 fear more than 6 months after infection. Greater fear was associated with sociodemographic factors, physical activity prior to COVID-19 and COVID-19 symptom severity. There is a need to target this population to develop appropriate interventions.

Indexed as

COVID-19AdultCross-Sectional StudiesEstoniaFamily PracticeFearFemaleHumansMaleMiddle AgedPhobic DisordersPost-Acute COVID-19 SyndromeSARS-CoV-2COVID-19 fear scaleFCV-19Slong covidpost covidprimary care

Identifiers

PMID37259825
PMCPMC10249452
OpenAlexW4378953213

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.